A Comprehensive Study on Nerivio Migra

  • Dr.Srinivas Pasula Department of Pharmacy Practice, Bhaskar College of Pharmacy, Amdapur X Road, Yenkapally, Moinabad, Ranga Reddy, Hyderabad, Telangana 500075
  • Ledo Thankachan Department of Pharmacy Practice, Bhaskar College of Pharmacy, Amdapur X Road, Yenkapally, Moinabad, Ranga Reddy, Hyderabad, Telangana 500075
    sreenu.pasula@gmail.com
  • Dr. A. Srionivasa Rao Department of Pharmacy Practice, Bhaskar College of Pharmacy, Amdapur X Road, Yenkapally, Moinabad, Ranga Reddy, Hyderabad, Telangana 500075
  • Dr.Beda Durga Prasad Department of Pharmacy Practice, Bhaskar College of Pharmacy, Amdapur X Road, Yenkapally, Moinabad, Ranga Reddy, Hyderabad, Telangana 500075

Abstract

Migraine is one among the foremost prevalent and disabling disorders, characterized by recurrent headache attacks with nausea, vomiting, photophobia, and phonophobia. Nerivio Migra may be a breakthrough device for acute treatment of migraines. Attached to the patient's arm (below the shoulder), it's a clinically-tested wearable suited to be worn everywhere and at any time. Non steroidal anti inflammatory drugs (NSAIDs) and triptans, commonly used for acute migraine treatment3, may be ineffective, poorly tolerated, contraindicated, and if used in excess, may lead to medication overuse headache there is a great unmet need for alternative acute migraine treatments that are both effective and well tolerated. Non-invasive neuromodulation is safe, well tolerated, and may have fewer adverse effects than drugs. Remote electrical neuromodulation (REN) may be a novel acute migraine treatment that stimulates upper arm peripheral nerves to induce conditioned pain modulation (CPM)-an endogenous analgesia mechanism during which conditioning stimulation inhibits pain in remote body regions.

Keywords: Migraine, Phonophobia, photophobia Remote electrical neuromodulation

Downloads

Download data is not yet available.

References

1. Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1211- 1259.
2. Society (IHS) HCC of the IH. The international classification of headache disorders, (beta version). Cephalalgia. 2013; 33: 629- 808
3. Silva AND, Tepper SJ. Acute treatment of migraines. CNS Drugs. 2012; 26: 823- 839.
4. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol. 2010; 9: 285- 298.
5. Diener H-C, Limmroth V. Medication-overuse headache: A worldwide problem. Lancet Neurol.2004; 3: 475- 483.
6. Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep. 2009; 13: 301- 307.
7. Katić BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME. Adherence to acute migraine medication: What does it mean, why does it matter? Headache. 2010; 50: 117- 129.
8. Bigal M, Krymchantowski AV, Lipton RB. Barriers to satisfactory migraine outcomes. What have we learned, where do we stand? Headache. 2009; 49: 1028- 1041.
9. Alam A, Munjal S, Reed M, et al. Triptan use and discontinuation in a representative sample of persons with migraine: Results from migraine in America symptoms and treatment (MAST) study (P4.10-019). Neurology. 2019; 92(Suppl. 15) P4.10-019.
10. Puledda F, Goadsby PJ. An update on non-pharmacological neuromodulation for the acute and preventive treatment of migraine. Headache. 2017; 57: 685- 691.
11. Starling A. Noninvasive neuromodulation in migraine and cluster headache. CurrOpin Neurol.2018; 31: 268- 273.
12. Nir R-R, Yarnitsky D. Conditioned pain modulation. CurrOpin Support Palliat Care. 2015; 9: 131- 137.
13. Yarnitsky D, Volokh L, Ironi A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017; 88: 1250- 1255.
Statistics
117 Views | 100 Downloads
Citatons
How to Cite
Pasula, S., T. Ledo, S. R. A, and D. P. Beda. “A Comprehensive Study on Nerivio Migra”. World Journal of Current Medical and Pharmaceutical Research, Vol. 2, no. 1, Feb. 2020, pp. 30-32, doi:10.37022/WJCMPR.2020.020110.
Section
Review Articles